UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Archives of biochemistry and biophysics, ISSN 0003-9861, 03/2019, Volume 663, p. 288
Journal Article
Journal of controlled release, ISSN 0168-3659, 03/2016, Volume 225, pp. 269 - 282
Cyclosporine A | Immunosuppressant | Microparticle | Nanoparticle | Drug delivery system | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Cyclosporine - therapeutic use | Animals | Cyclosporine - chemistry | Cyclosporine - pharmacology | Humans | Immunosuppressive Agents - therapeutic use | Cyclosporine - administration & dosage | Drug Compounding | Immunosuppressive Agents - pharmacology | Immunosuppressive Agents - administration & dosage | Immunosuppressive Agents - chemistry | Drug Delivery Systems | Strategic planning (Business) | Orphan drugs | Cyclosporine | Index Medicus
Journal Article
The Journal of immunology (1950), ISSN 0022-1767, 12/2013, Volume 191, Issue 12, pp. 5785 - 5791
Life Sciences & Biomedicine | Immunology | Science & Technology | Meta-Analysis as Topic | History, 21st Century | Cyclosporine - pharmacology | Humans | Immunosuppressive Agents - therapeutic use | Tacrolimus - history | Calcineurin Inhibitors | Multicenter Studies as Topic | Immunosuppressive Agents - history | T-Lymphocytes - drug effects | Kidney Diseases - chemically induced | Tacrolimus - pharmacology | Drug Evaluation, Preclinical | Drug Therapy, Combination | Immunosuppressive Agents - pharmacology | Autoimmune Diseases - drug therapy | Cyclosporine - history | Kidney Transplantation - history | Graft Rejection - prevention & control | History, 20th Century | Tacrolimus - chemistry | Kidney Diseases - drug therapy | Clinical Trials as Topic | Tacrolimus - adverse effects | Forecasting | Randomized Controlled Trials as Topic | Calcineurin - physiology | Kidney Diseases - immunology | Cyclosporine - therapeutic use | Tacrolimus - therapeutic use | Animals | Cyclosporine - chemistry | Lymphocyte Activation - drug effects | Cyclosporine - adverse effects | Immunosuppressive Agents - adverse effects | T-Lymphocytes - immunology | Diabetes Mellitus, Type 2 - chemically induced | Immunosuppressive Agents - chemistry | Index Medicus | Abridged Index Medicus
Journal Article
La revue de medecine interne, ISSN 0248-8663, 11/2010, Volume 31, Issue 11, p. e7-e8
Journal Article
International journal of pharmaceutics, ISSN 0378-5173, 09/2014, Volume 472, Issue 1-2, pp. 10 - 19
Cyclosporine A | Chitosan | Films | Ocular | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | 2-Hydroxypropyl-beta-cyclodextrin | Interleukin-2 - metabolism | Administration, Ophthalmic | Cell Line | Cell Survival - drug effects | Adhesiveness | Humans | Chitosan - administration & dosage | Plasticizers - chemistry | Drug Delivery Systems | Chitosan - chemistry | beta-Cyclodextrins - chemistry | Excipients - chemistry | Cyclosporine - chemistry | Mucous Membrane - chemistry | Cyclosporine - administration & dosage | Water - chemistry | Glycerol - chemistry | Digital integrated circuits | Cyclosporine | Index Medicus
Journal Article
American journal of transplantation, ISSN 1600-6135, 08/2011, Volume 11, Issue 8, pp. 1665 - 1675
Chronic allograft nephropathy | CsA | nephrotoxicity | SRL conversion | renal transplantation | MMF | renal function | Transplantation | Life Sciences & Biomedicine | Surgery | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | Miscellaneous | Nephropathies. Renovascular diseases. Renal failure | Renal failure | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases | Surgery of the urinary system | Kidney Failure, Chronic - physiopathology | Sirolimus - therapeutic use | Kidney Failure, Chronic - surgery | Cyclosporine - pharmacology | Humans | Immunosuppressive Agents - therapeutic use | Kidney Failure, Chronic - drug therapy | Middle Aged | Graft Survival | Male | Survival Rate | Kidney Transplantation | Sirolimus - pharmacology | Kidney Function Tests | Cyclosporine - therapeutic use | Cyclosporine - adverse effects | Adult | Female | Immunosuppressive Agents - adverse effects | Immunosuppressive Agents - pharmacology | Sirolimus - adverse effects | Immunosuppressive agents | Kidney diseases | Diabetes | Index Medicus | Immunosuppressive Agents | Sirolimus | Cyclosporine | Life Sciences | Kidney Failure, Chronic | Pharmaceutical sciences
Journal Article
European journal of pharmaceutical sciences, ISSN 0928-0987, 10/2014, Volume 62, pp. 16 - 22
Cyclosporine A | Self-micellization | Solid dispersion | Stability | Dissolution | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Cell Line | Cell Survival - drug effects | Drug Stability | Immunosuppressive Agents - pharmacokinetics | Solubility | Biological Availability | Male | Methacrylates - chemistry | Phosphorylcholine - analogs & derivatives | Rats, Sprague-Dawley | Chemistry, Pharmaceutical | Cyclosporine - blood | Animals | Immunosuppressive Agents - blood | Cyclosporine - chemistry | Micelles | Cyclosporine - administration & dosage | Cyclosporine - pharmacokinetics | Phosphorylcholine - chemistry | Immunosuppressive Agents - administration & dosage | Immunosuppressive Agents - chemistry | Cyclosporine | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 07/2008, Volume 359, Issue 5, pp. 473 - 481
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | General aspects | Medical sciences | Coronary heart disease | Single-Blind Method | Creatine Kinase - blood | Mitochondrial Membrane Transport Proteins - antagonists & inhibitors | Area Under Curve | Humans | Middle Aged | Male | Combined Modality Therapy | Biomarkers - blood | Troponin I - blood | Cyclosporine - blood | Angioplasty, Balloon, Coronary - adverse effects | Cyclosporine - therapeutic use | Magnetic Resonance Imaging | Myocardial Infarction - therapy | Pilot Projects | Myocardial Infarction - drug therapy | Cyclosporine - adverse effects | Myocardial Infarction - pathology | Female | Myocardial Reperfusion Injury - prevention & control | Premedication | Evaluation | Dosage and administration | Cyclosporine | Drug therapy | Heart attack | Heart attacks | Medical imaging | Permeability | Ischemia | Cardiology | Veins & arteries | Index Medicus | Abridged Index Medicus | Life Sciences | Other
Journal Article
European journal of clinical pharmacology, ISSN 0031-6970, 6/2014, Volume 70, Issue 6, pp. 685 - 693
CYP3A | POR | Biomedicine | Calcineurin inhibitors | Kidney recipients | Pharmacology/Toxicology | Pharmacokinetics | PPARA | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Biological and medical sciences | Pharmacology. Drug treatments | Medical sciences | NADPH-Ferrihemoprotein Reductase - genetics | Humans | Immunosuppressive Agents - pharmacokinetics | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Cyclosporine - blood | Dose-Response Relationship, Drug | Young Adult | Immunosuppressive Agents - blood | Cytochrome P-450 CYP3A - genetics | Cyclosporine - pharmacokinetics | Adult | Female | Retrospective Studies | Real-Time Polymerase Chain Reaction | Immunosuppressive Agents - administration & dosage | Tacrolimus - administration & dosage | Tacrolimus - blood | Gene Frequency | Genotype | PPAR alpha - genetics | Kidney Transplantation | Tacrolimus - pharmacokinetics | Cyclosporine - therapeutic use | Tacrolimus - therapeutic use | Analysis of Variance | Polymorphism, Restriction Fragment Length | Cyclosporine - administration & dosage | Aged | Kidneys | Tacrolimus | Cytochrome P-450 | Genetic research | Physiological aspects | Drugstores | Organ transplant recipients | Transplantation | Cyclosporine | Genetics | Pharmacology | Transplants & implants | Index Medicus | Pharmacogenetics
Journal Article
European journal of pharmaceutical sciences, ISSN 0928-0987, 01/2017, Volume 96, pp. 107 - 114
Cyclosporine A | Respirable powder | Self-micellizing solid dispersion | Dissolution | Systemic side effect | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Allergens | Blood Urea Nitrogen | Cell Count | Immunosuppressive Agents - pharmacokinetics | Male | Drug Delivery Systems | Cyclosporine - blood | Tissue Distribution | Kidney - metabolism | Immunosuppressive Agents - blood | Micelles | Cyclosporine - pharmacokinetics | Bronchoalveolar Lavage Fluid - cytology | Lung - metabolism | Immunosuppressive Agents - administration & dosage | Ovalbumin | Lung - pathology | Microscopy, Electron, Scanning | Liver - metabolism | Solubility | Administration, Inhalation | Rats, Sprague-Dawley | Bilirubin - blood | Animals | Cyclosporine - chemistry | Lung - drug effects | Cyclosporine - administration & dosage | Creatinine - blood | Bronchoalveolar Lavage Fluid - chemistry | Immunosuppressive Agents - chemistry | Peroxidase - metabolism | Analysis | Safety and security measures | Cyclosporine | Phosphates | Urea | Methylcellulose | Lactose | Powders | Liver | Albumin | Index Medicus
Journal Article